MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Gene panel testing in movement disorders: an efficient approach highlighting overlaps and heterogeneity

S. Montaut, C. Tranchant, N. Drouot, G. Rudolf, C. Guissart, J. Tarabeux, T. Stemmelen, A. Velt, C. Fourrage, P. Nitschke, B. Gerard, JL. Mandel, M. Koenig, J. Chelly, M. Anheim (Paris, France)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Generalised Polymyoclonus In a Patient With Central Nervous System Tuberculosis

K. Shahedah, MS. Mohamad Salmi (Pahang, Malaysia)

Myoclonus  ·  Les Muses, Level 3
1:45pm-3:15pm
Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson’s disease

L. Qin, L. Shu, B. Tang, Q. Xu (Changsha, China)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Genetic diagnosis of Chorea-acanthocytosis using whole exome sequencing revealed novel VPS13A Gene mutation

H. Ryu, C. Hong, J. Lee (Daegu, Republic of Korea)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3
1:45pm-3:15pm
Genetic markers revealed in dysregulated pathways in ischemic stroke may lead to Parkinson’s disease

H. Singh, V. Swarup, A. Srivastava (Marseille, France)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Genetic panel testing in Parkinson’s disease

T. Toomsoo, I. Rubanovich, I. Kalju, S. Ott, A. Lindmäe, M. Mällo, K. Jaakson, K. Joost, K. Vender (Tallinn, Estonia)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Genetic polymorphism (rs6971) in translocator protein (TSPO) and its clinical relevance in Parkinson’s disease

P. Surathi, M. Matarazzo, A. Sethi, J. Mckenzie, N. Neilson, R. Ross, M. Schulzer, M. Farrer, S. Booromand, J. Stoessl (Vancouver, BC, Canada)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Genetic study of patients with Parkinson’s disease subjected to second line therapies

F. Carrillo, S. Jesus, T. Periñan, R. Escuela, D. Buiza, MA. Labrador, M. Carrión, A. Adarmes, D. Macias, P. Gomez-Garre, P. Mir (Seville, Spain)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Genetics of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) – A Preliminary Demographic profile

P. Kukkle, V. Goyal, R. Kandadai, R. Borgohain, H. Kumar, A. Mukherjee, A. Biswas, S. Das, U. Muthane, S. Desai, P. Wadia, P. Pal, R. Yadav, V. Ramprasad (Bangalore, India)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Genotype-Phenotype correlations of Episodic Ataxia (EA). MDSGene Systematic Review

A. Shetty, K. Nabieva, F. Zeldenrust, A. Rasheed, J. Huang, S. Petkovic, K. Lohmann, C. Klein, C. Marras, O. Waln (Lübeck, Germany)

Ataxia  ·  Les Muses, Level 3
  • «Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley